Invention Grant
- Patent Title: Drug eluting ocular implant
-
Application No.: US13989037Application Date: 2011-11-22
-
Publication No.: US09668915B2Publication Date: 2017-06-06
- Inventor: David Haffner , Ken Curry , Harold Heitzmann , David Applegate
- Applicant: David Haffner , Ken Curry , Harold Heitzmann , David Applegate
- Applicant Address: US CA San Clemente
- Assignee: DOSE MEDICAL CORPORATION
- Current Assignee: DOSE MEDICAL CORPORATION
- Current Assignee Address: US CA San Clemente
- Agency: Knobbe Martens Olson & Bear, LLP
- International Application: PCT/US2011/061967 WO 20111122
- International Announcement: WO2012/071476 WO 20120531
- Main IPC: A61F9/00
- IPC: A61F9/00 ; A61F9/007 ; A61K9/00 ; A61K9/20

Abstract:
Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
Public/Granted literature
- US20130289467A1 DRUG ELUTING OCULAR IMPLANT Public/Granted day:2013-10-31
Information query